Psoriasis: all 1,928 studies

Page 3 of 20. Open to participants first (234), then studies with results posted, then the rest; newest registration first within each.

• Personal Precise Treatment on Psoriasis and Psoriatic ArthritisNot yet recruitingNCT04915105Not applicable
• the Efficacy and Safety of Etanercept （Yi Sai Pu) in Chinese Patients With Moderate-to-Severe PsoriasisRecruitingNCT04912401
• Metabolic Profiling of Immune Responses in Immune-mediated DiseasesRecruitingNCT04864886
• Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchRecruitingNCT04806620
• Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in PsoriasisRecruitingNCT04785027Phase 1/2
• A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque PsoriasisRecruitingNCT04772079Phase 3
• Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsRecruitingNCT04751396
• Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque PsoriasisRecruitingNCT04537689Phase 4
• Chinese Psoriasis Real World Evidence ResearchRecruitingNCT04465838
• Taltz in Combination With Enstilar for PsoriasisRecruitingNCT04372277Phase 4
• International Rare And Severe Psoriasis Expert NetworkRecruitingNCT04359394
• ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.RecruitingNCT04347473Phase 4
• Outcomes With Treatment and Withdraw of Secukinumab in Patients With Plaque PsoriasisNot yet recruitingNCT04239859Phase 4
• Evolution and Treatments of Chronic Inflammatory Systemic DiseasesRecruitingNCT04191395
• GOTHA - The Early Arthritis and Psoriasis Study of Region Västra Götaland, SwedenEnrolling by invitationNCT04190758
• Skin Microbial Ecology in Atopic DermatitisRecruitingNCT04170244
• Duobrii in Combination With BiologicsRecruitingNCT04119102Phase 4
• Therapeutic Drug Monitoring of Brodalumab in Psoriasis Patients (BIOLOPTIM-BRO)RecruitingNCT04080635Not applicable
• Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia AreataEnrolling by invitationNCT03976622
• Enstilar in Combination With Enbrel or Humira for Plaque PsoriasisRecruitingNCT03827876Phase 4
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVORecruitingNCT03816345Phase 1
• An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis PatientsRecruitingNCT03392337Not applicable
• Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and PsoriasisRecruitingNCT03361215
• Molecular Signatures in Inflammatory Skin DiseaseRecruitingNCT03358693
• LTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe PsoriasisEnrolling by invitationNCT03254667
• Regulation of Inflammatory Genes in PsoriasisRecruitingNCT03125655
• Glucocorticoid-induced Osteoporosis in Patients With Chronic Inflammatory Rheumatic Diseases or PsoriasisRecruitingNCT02719314
• The CorEvitas Psoriasis (PSO) RegistryRecruitingNCT02707341
• Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic ArthritisRecruitingNCT02572700
• Effects of Treatment With Biological Agents on Vascular and Cardiac Function in PsoriasisRecruitingNCT02144857Phase 4
• Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy ProjectRecruitingNCT02103361
• Spanish Registry of Systemic Treatments in PsoriasisRecruitingNCT02075697
• PsoBest - the German Psoriasis RegistryRecruitingNCT01848028
• Swiss Dermatology Network of Targeted Therapies (SDNTT)RecruitingNCT01706692
• A Study to Assess Efficacy and Tolerability of Topical Skincare Products on Psoriasis PatientsCompletedNCT06357221Phase 4Results posted
• A Study of JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic PsoriasisActive, not recruitingNCT06295692Phase 3Results posted
• A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque PsoriasisCompletedNCT06073119Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque PsoriasisCompletedNCT06011733Phase 3Results posted
• Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp PsoriasisCompletedNCT05969223Phase 4Results posted
• A Study to Evaluate the Efficacy and Safety of DC-806 in Participants With Moderate to Severe Plaque PsoriasisCompletedNCT05896527Phase 2Results posted
• A Study to Assess Treatment Satisfaction, Patient-reported Outcomes, Effectiveness, and Safety of a Fixed-dose Combination of Calcipotriene/Betamethasone Dipropionate PAD Cream in the Treatment of Mild-to-moderate Plaque Psoriasis of the Scalp in AdultsCompletedNCT05811234Results posted
• A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or PsoriasisCompletedNCT05796245Results posted
• A Study to Investigate Efficacy and Safety of VTAMA® (Tapinarof) Cream, 1% in Plaque Psoriasis in the Head and Neck RegionCompletedNCT05789576Phase 4Results posted
• A Randomized, Open, Parallel, Controlled, Multi-center, Interventional, Cross-sectional Study to Evaluate the Detection Rate of Psoriatic Arthritis in Korean Moderate-to-severe Psoriasis Patients, With or Without Active Screening for Arthritis in Psoriasis (ASAP Study)CompletedNCT05758402Not applicableResults posted
• A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe PsoriasisCompletedNCT05730725Phase 2Results posted
• Deucravacitinib for the Treatment of Palmoplantar PustulosisTerminatedNCT05710185Phase 4Results posted
• A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community SettingCompletedNCT05701995Phase 4Results posted
• A Study to Investigate Efficacy and Safety of VTAMA (Tapinarof) Cream, 1% in Intertriginous Plaque PsoriasisCompletedNCT05680740Phase 4Results posted
• Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic ArthritisCompletedNCT05640245Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Plaque PsoriasisCompletedNCT05600036Phase 2Results posted
• Safety and Tolerability Study of MSC Exosome OintmentCompletedNCT05523011Phase 1Results posted
• Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp PsoriasisCompletedNCT05478499Phase 4Results posted
• A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.CompletedNCT05375955Phase 2Results posted
• Study to Evaluate the Long-Term Safety and Efficacy of Imsidolimab (ANB019) in the Treatment of Subjects With GPPTerminatedNCT05366855Phase 3Results posted
• Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Subjects With GPPCompletedNCT05352893Phase 3Results posted
• High Dose Risankizumab for PsoriasisCompletedNCT05283135Phase 2Results posted
• Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque PsoriasisCompletedNCT05268016Phase 2Results posted
• An Expanded Access Program in China to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment OptionsCompletedNCT05239039Phase 3Results posted
• An Expanded Access Trial in Japan to Provide Spesolimab to People With a Flare-up in Generalized Pustular Psoriasis Who Have no Other Treatment OptionsCompletedNCT05200247Phase 3Results posted
• A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP)TerminatedNCT05194839Phase 2Results posted
• Study to Assess the Efficacy and Safety of Orismilast in PsoriasisCompletedNCT05190419Phase 2Results posted
• Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)CompletedNCT05174065Phase 3Results posted
• Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque PsoriasisTerminatedNCT05125679Phase 4Results posted
• A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque PsoriasisCompletedNCT05073315Phase 3Results posted
• A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe PsoriasisTerminatedNCT05044234Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Korean Study Participants With Moderate to Severe Plaque PsoriasisCompletedNCT05020249Phase 3Results posted
• Study of NDI-034858 in Participants With Moderate to Severe Plaque PsoriasisCompletedNCT04999839Phase 2Results posted
• A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to Stelara® in Subject With Moderate to Severe Plaque PsoriasisCompletedNCT04967508Phase 3Results posted
• A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque PsoriasisCompletedNCT04908514Phase 2Results posted
• Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic TherapyCompletedNCT04908475Phase 4Results posted
• Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT04785326Phase 3Results posted
• A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk FactorsCompletedNCT04776629Phase 2Results posted
• A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque PsoriasisCompletedNCT04761627Phase 3Results posted
• Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-216)CompletedNCT04746911Phase 2Results posted
• Combination of Halobetasol Propionate and Tazarotene Lotion (Duobrii®) for Palmoplantar Plaque Type PsoriasisCompletedNCT04720105Phase 4Results posted
• A Study to Assess the Pharmacokinetics, Safety, and Efficacy of Two Doses of Bimekizumab in Adolescent Study Participants With Moderate to Severe Plaque PsoriasisCompletedNCT04718896Phase 2Results posted
• Brain Changes in Psoriasis After Secukinumab TreatmentCompletedNCT04717466Phase 4Results posted
• Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar InvolvementCompletedNCT04713592Phase 3Results posted
• A Study to Compare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque PsoriasisCompletedNCT04673786Phase 3Results posted
• Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque PsoriasisCompletedNCT04664153Phase 2Results posted
• Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Children With Plaque Psoriasis (ARQ-151-215)CompletedNCT04655313Phase 2Results posted
• Rimegepant in Moderate Plaque-type PsoriasisCompletedNCT04629950Phase 2Results posted
• A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque PsoriasisCompletedNCT04607980Phase 3Results posted
• A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque PsoriasisCompletedNCT04603027Phase 2Results posted
• Apremilast in Patients With Moderate to Severe Palmoplantar Pustulosis (PPP) (APLANTUS)CompletedNCT04572997Phase 2Results posted
• Predicting Inflammatory Skin Disease Response to IL-23 BlockadeCompletedNCT04541329Phase 4Results posted
• Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to UstekinumabTerminatedNCT04533737Phase 4Results posted
• A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With SpesolimabTerminatedNCT04493424Phase 2Results posted
• A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease SymptomsCompletedNCT04435600Phase 3Results posted
• Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).CompletedNCT04428411Results posted
• A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular PsoriasisCompletedNCT04399837Phase 2Results posted
• Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis PatientsCompletedNCT04398732Results posted
• Blue Light PhototherapyCompletedNCT04343586Not applicableResults posted
• A Study to Evaluate the Benefit and Safety of GSK2982772 in Moderate to Severe Psoriasis ParticipantsCompletedNCT04316585Phase 1Results posted
• Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque PsoriasisTerminatedNCT04305327Phase 3Results posted
• Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in PsoriasisCompletedNCT04271735Not applicableResults posted
• MIcrovascular dysfuNction In Moderate-severe PsoriasisCompletedNCT04271540Phase 4Results posted
• Tofacitinib for Immune Skin Conditions in Down SyndromeCompletedNCT04246372Phase 2Results posted
• A Study of Secukinumab Treatment in Patients With Plaque Psoriasis and Coexisting Non-alcoholic Fatty Liver Disease (NAFLD)TerminatedNCT04237116Phase 3Results posted
• A Study Evaluating the Efficacy and Tolerability of Enstilar Foam in Patients With Nail PsoriasisCompletedNCT04227288Phase 4Results posted

← Psoriasis overview